Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Karuna schizophrenia drug achieves study goals in late-stage trial

admin by admin
August 8, 2022
in Pharmaceutical



Karuna Therapeutics said Monday that a novel combination pill reduced psychosis and related symptoms experienced by patients with schizophrenia, achieving the main goals of a late-stage clinical trial.

With positive study results in hand, the Boston-based biotech intends to submit a marketing application with the Food and Drug Administration by the middle of next year. If approved, the Karuna drug would usher in the first new class of medicines for the treatment of schizophrenia in decades.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED





Source link

Previous Post

What Is Known About The Virus Strain

Next Post

Cannabis Allergies; Polio in Wastewater; Violent Patients

Next Post

Cannabis Allergies; Polio in Wastewater; Violent Patients

Recommended

Illinois Daycare Staff, Children Potentially Exposed To Monkeypox After Worker Tests Positive

August 7, 2022

Postpartum Depression Risk Higher With Family Psych History

August 20, 2022

Don't miss it

Pharmaceutical

ALS Association battles its chapters over money, priorities

February 3, 2023
Medicines & Healthy Lifestyle

Surgery and Prescriptions Now Advised for Obese Children?

February 3, 2023
Medicines & Healthy Lifestyle

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

February 3, 2023
Medicines & Healthy Lifestyle

Prescribing Medication Dosage According To DNA Profile Lowers Side Effects By 30%: Study

February 3, 2023
News

Longer Diabetes Duration Links With Increased Heart Failure

February 3, 2023
Pharmaceutical

Health Bulletin 3/ February/ 2023

February 3, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.